Bovie Medical Corporation , a maker of medical devices and supplies and the developer of J-Plasma®, a patented new surgical product, announced today that it has closed the sale of an additional 418,749 shares of its common stock pursuant to the over-allotment option of the underwriter in connection with its recent public offering of common stock.
from Content Keyword RSS http://ift.tt/1Dmd08b
via IFTTT
from Content Keyword RSS http://ift.tt/1Dmd08b
via IFTTT
No comments:
Post a Comment